Healthcare entity

Courtney Miller

Person

Every one of those 1 sits in a single category, funding. Courtney Miller is most often covered alongside BioFlorida, which appears in 1 of these 1 story. Each story carries 2 original sources on average, compared with 2.3 for the broader beat in this window.

Last mentioned: Mar 10, 2026

Entity pulse

Recent coverage · Courtney Miller

1 story
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Courtney Miller

Every one of those 1 sits in a single category, funding. Courtney Miller is most often covered alongside BioFlorida, which appears in 1 of these 1 story. Each story carries 2 original sources on average, compared with 2.3 for the broader beat in this window. Their average consequence score of 5 runs below the beat's 5.9 for that window. We currently track 1 Healthcare story that mention Courtney Miller, all published on March 10, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 39 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Courtney Miller. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. BioFlorida Showcase

    Cornerstone Session presentation on innovation in the regional ecosystem.

  2. Investival Showcase

    Presentation at the South Florida Rising Life Science Hub event.

  3. Conference Invitations

    Announced invitations to two major South Florida life sciences showcases.

  4. National Partnering

    Presented at BioCom California Global Life Science Partnering Conference.

Stories mentioning Courtney Miller 1

Funding Neutral

Myosin Therapeutics Showcases Nanomotor Platform Amid South Florida Biotech Surge

Myosin Therapeutics has been selected to present its first-in-class nanomotor-dependency platform at two major South Florida life sciences conferences in March 2026. The company is advancing MT-125, a dual NMIIA/IIB inhibitor currently in Phase 1/2 trials for glioblastoma, targeting the physical mechanics of cancer cells to bypass traditional resistance.

2 sources

Source: prnewswire.com · admin (in)

Courtney Miller is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.